ALX Oncology Holdings Inc (ALXO) reports promising clinical trial results and a strengthened financial outlook, despite some delays in data readouts.

Endometrial cancer (EC) incidence is rising globally, yet therapeutic progress has lagged behind other solid tumors, in part due to the complexity and ...

ALX Oncology (NASDAQ:ALXO) outlined progress across its two core programs—CD47 blocker evorpacept and EGFR-targeted ...

Floodlight reports Louisiana is investing in "blue ammonia," raising concerns among locals about health risks from proposed ...

King Faisal Specialist Hospital and Research Centre (KFSH) in Riyadh has successfully introduced a pioneering high-intensity focused ultrasound (HIFU) treatment for prostate cancer for the first time ...

New fasting feature offers beginner to advanced fasting plans, real-time tracking, fasting stage education, and ...

Women with stage IV breast cancer detected through screening have a 60% chance of survival 10 years after diagnosis. This is in comparison to a survival rate of under 20% of those with stage IV breast ...

Fifteen years ago, Beijing's Liangma riverbanks would have been smog-choked and deserted in winter, but these days they are dotted with families and exercising pensioners most mornings.

This story is from Floodlight, a nonprofit newsroom that investigates the powerful interests stalling climate action. Sign up ...

Dr. Elias Obeid says ongoing monitoring after treatment helps detect recurrence early and identify late effects, supporting survivorship for patients. Ongoing monitoring remains a cornerstone of ...

We knew we had something interesting with T3p, a single small RNA found in breast cancer but absent from normal tissue. After being described in 2018, this molecule took our team on a six-year journey ...

When someone gets a cancer diagnosis, the initial reaction is usually to undergo treatment as quickly as possible — but for some types of disease, doctors may recommend a more conservative approach.